Hide metadata

dc.date.accessioned2024-02-20T18:13:26Z
dc.date.available2024-02-20T18:13:26Z
dc.date.created2023-11-10T13:20:33Z
dc.date.issued2023
dc.identifier.citationMallick, Rahul Bhowmik, Prasenjit Duttaroy, Asim Kanti . Targeting fatty acid uptake and metabolism in cancer cells: A promising strategy for cancer treatment. Biomedicine & Pharmacotherapy. 2023, 167
dc.identifier.urihttp://hdl.handle.net/10852/108362
dc.description.abstractDespite scientific development, cancer is still a fatal disease. The development of cancer is thought to be significantly influenced by fatty acids. Several mechanisms that control fatty acid absorption and metabolism are reported to be altered in cancer cells to support their survival. Cancer cells can use de novo synthesis or uptake of extracellular fatty acid if one method is restricted. This factor makes it more difficult to target one pathway while failing to treat the disease properly. Side effects may also arise if several inhibitors simultaneously target many targets. If a viable inhibitor could work on several routes, the number of negative effects might be reduced. Comparative investigations against cell viability have found several potent natural and manmade substances. In this review, we discuss the complex roles that fatty acids play in the development of tumors and the progression of cancer, newly discovered and potentially effective natural and synthetic compounds that block the uptake and metabolism of fatty acids, the adverse side effects that can occur when multiple inhibitors are used to treat cancer, and emerging therapeutic approaches.
dc.languageEN
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleTargeting fatty acid uptake and metabolism in cancer cells: A promising strategy for cancer treatment
dc.title.alternativeENEngelskEnglishTargeting fatty acid uptake and metabolism in cancer cells: A promising strategy for cancer treatment
dc.typeJournal article
dc.creator.authorMallick, Rahul
dc.creator.authorBhowmik, Prasenjit
dc.creator.authorDuttaroy, Asim Kanti
cristin.unitcode185,51,13,20
cristin.unitnameSeksjon for klinisk ernæring
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin2195081
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Biomedicine & Pharmacotherapy&rft.volume=167&rft.spage=&rft.date=2023
dc.identifier.jtitleBiomedicine & Pharmacotherapy
dc.identifier.volume167
dc.identifier.pagecount20
dc.identifier.doihttps://doi.org/10.1016/j.biopha.2023.115591
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn0753-3322
dc.type.versionPublishedVersion
cristin.articleid115591


Files in this item

Appears in the following Collection

Hide metadata

Attribution 4.0 International
This item's license is: Attribution 4.0 International